This report analyzes the Global market for H1N1 Vaccines in US$ Million.
Annual estimates and forecasts are provided for the period 2009 through 2015.
The report profiles 21 companies including Baxter International, Inc., CPL
Biologicals Pvt. Ltd., CSL Limited, GlaxoSmithKline Plc, MedImmune, LLC,
Novartis AG, Sanofi Pasteur, SA, Simcere Pharmaceutical Group, Sinovac Biotech
Ltd., Solvay SA, and Zydus Cadila. Market data and analytics are derived from
primary and secondary research. Company profiles are mostly extracted from URL
research and reported select online sources.
Table of Contents
Table of Contents
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
II. EXECUTIVE SUMMARY
1. GLOBAL MARKET OVERVIEW
Influenza A (H1N1) 2009: The Global Pandemic
Swine Flu Badly Hits Economy
H1N1 Concerns Spell Boom for Hand Sanitizers Market
H1N1 Vaccines: A Weapon to Combat the New Flu Virus
US DHHS Allocates US$1 Billion for Developing H1N1 Vaccine
H1N1 Vaccines Hit the Market in August 2009
H1N1 Influenza Vaccines and Manufacturers
Specific Anti-Viral Drugs Witness Increasing Orders
Pharma Majors Try Combination Therapies Against H1N1
Need for Effective Anti-Virals Against H1N1 Virus Grows
H1N1 Pandemic Now "Moderately" Severe
Demand for H1N1 Vaccines to Gradually Fade
Current and Future Analysis
2. A REVIEW OF SELECT H1N1 VACCINES
Celtura(r) (Novartis)
Focetria(r) (Novartis)
Fluvirin(r) (Novartis)
Panenza(r) (Sanofi Pasteur)
Humenza (Sanofi Pasteur)
Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)
Major H1N1 Vaccines Available in Different Geographic Regions
H1N1 Influenza Vaccines Available in Europe, by Select Region
FDA-Approved H1N1 Vaccines in the US, By Manufacturer
H1N1 Vaccines Approved For Use in Canada
H1N1 Flu Vaccines Available in Asia Pacific, by Select Country/Region
H1N1 Flu Vaccines Available in Other Selected Global Country/Region
3. REGIONAL MARKET PERSPECTIVE
India
Zydus Becomes the First Company to Register H1N1 Clinical Trials in India
India May Expect H1N1 Vaccine by April 2010
Generic Anti-Virals Abound for H1N1 Treatment
Table 1: Major Oseltamivir Generics in India, Breakdown by Cost (includes
corresponding Graph/Chart)
China
China Boosts (H1N1) Influenza A Vaccines Volume
Over 3.7 Million Chinese Immunized Against H1N1
Singapore
Singapore Health Ministry Bolsters National Stockpile of H1N1 Vaccines
Australia
Australian Government Awards Supply Contract to CSL Ltd
Europe
Select European Countries to Return Unused Vaccines
4. WORLDWIDE H1N1 PANDEMIC SITUATION
North America
Mexico
The United States
Canada
Japan
Europe
Asia-Pacific
Hong Kong
South Korea
Taiwan
Malaysia
Philippines
Singapore
India
Australia
New Zealand
H1N1 Cases Worldwide - A Statistical Review by Select Geographic Region
Table 2: H1N1 Pandemic Situation in Select Countries Worldwide: Confirmed
Cases and Deaths Due to the Infection (includes corresponding Graph/Chart)
Table 3: Pandemic (H1N1) Situation by Select Global Country: Suspected
Cases and Confirmed Deaths Due to the Infection (includes corresponding
Graph/Chart)
Table 4: Select Global Countries with Suspected H1N1 Cases, But no Deaths
(includes corresponding Graph/Chart)
5. H1N1 INFLUENZA - A RESPIRATORY VIRUS
What are Respiratory Viruses?
Influenza Virus: A Quick Primer
Symptoms and Characteristics
Types of Influenza
Influenza A Virus
Influenza A (H1N1) Virus
Different Names, in Different Countries
Symptoms and Risk Factors
Seasonal Influenza Vis-a-Vis H1N1 Flu
How H1N1 Is Diagnosed?
Prevention, and Vaccination Against H1N1
Prevention
Vaccination
How H1N1 Vaccine is Prepared?
Egg-Based Production Process
Cell Culture-Based Technology
Side Effects of H1N1 Vaccine
Primary Targets for Vaccination
Adverse Group for Vaccination
Treatment for Swine-Flu Infected Individuals
Anti-Virals for Pandemic (H1N1) 2009 Infection
Recommended Dosage of Anti-Virals
Peramivir - An Investigational Antiviral for H1N1
6. REGULATORY APPROVALS
CSL Biotherapies Receives TGA Approval for Panvax(r) H1N1
WHO Prequalifies Arepanrix(tm) H1N1 Vaccine of GlaxoSmithKline
CSL Obtains Approval for Extended Use of 2009 HINI Influenza vaccine in
Infants
Novartis Receives Approval for Celtura(r)
Baxter Obtains Approval for Vero Cell-Based CELVAPAN H1N1 Vaccine in Europe
CHMP Recommends Approval of Novartis' Focetria(r) in Europe
Sanofi Pasteur Obtains License from the US FDA for Influenza A (H1N1) 2009
Monovalent Vaccine
Sanofi Pasteur Receives Approval for New Vaccine Production Facility
US FDA Approves Supplemental BLA of GSK, for Unadjuvanted Influenza A
(H1N1) Pandemic Vaccine
Health Canada Approves H1N1 Virus Vaccine
Sanofi Pasteur Gains Approval of Afssaps for A (H1N1) 2009 Vaccine in
France
Novartis Obtains Prequalification Status from the WHO for Supply of
Influenza A (H1N1) 2009 Vaccines in Developing World
Novartis Obtains Swissmedic Approval for Celtura(r)
CSL Biotherapies Receives US FDA Licensure for its Thimerosal-free
Pandemic Influenza A (H1N1) 2009 Monovalent Vaccine
MedImmune Receives US FDA Approval for Nasal Spray H1N1 Vaccine
Sinovac Obtains Revised Approval for PANFLU.1 (H1N1) from State Food and
Drug Administration
Sinovac Gains Certificate of Approval for Supply of PANFLU.1 in Mexico
Jiangsu Yanshen Gains Manufacturing License from SFDA, for H1N1 Flu Vaccine
7. RECENT INDUSTRY ACTIVITY
Sinovac Biotech Clinches Fifth Consecutive Supply Order from MIIT for
Panflu.1 H1N1 Vaccine
Zydus Cadila Completes Phase I Clinical Trial With its H1N1 Vaccine
Cadila Pharmaceuticals and Novavax Launches CPL Biologicals Pvt. Ltd.
Novartis Delivers 7.5 Million Doses of Influenza A (H1N1) Vaccine to HHS
Novartis Opens New Production Facility for Cell Culture-Based Influenza
Vaccines Production in the United States
Novartis to Takeover Majority Interest in Chinese H1N1 Vaccine Maker
PhageVax Launches DNA Vaccine Platform
NIH to Initiate 2009 H1N1 Influenza Vaccine Trial in Persons with Asthma
Inovio Teams Up with Canadian Health Agency Pennsylvanian University on
Swine Flu Vaccine
Simcere to Acquire Majority Interest in ChinaVax
Sanofi Pasteur Clinches Additional Order from HHS Department of the US
Sanofi Pasteur Bags Order from French Health Ministry, for Influenza A
(H1N1) Vaccine
Sanofi Pasteur Inks Deal with Butantan Institute for Supply of Influenza A
(H1N1) Virus Vaccine
McKesson Extends Partnership Deal with CDC
BD Receives Order from the Department of HHS
GSK Receives Order from the Department of HHS
MedImmune Recalls 4.7 Million Courses of Nasal H1N1 Flu Vaccine
Novavax and Xcellerex Enter into a Partnership
8. FOCUS ON SELECT GLOBAL PLAYERS
Baxter International, Inc. (US)
CPL Biologicals Pvt. Ltd (India)
CSL Limited (Australia)
GlaxoSmithKline Plc (UK)
MedImmune, LLC. (USA)
Novartis AG (Switzerland)
Sanofi Pasteur, SA (France)
Simcere Pharmaceutical Group (China)
Sinovac Biotech Ltd (China)
Solvay SA (Belgium)
Zydus Cadila (India)
9. GLOBAL MARKET PERSPECTIVE
Table 5: World Recent Past, Current & Future Analysis for H1N1
Vaccines by Geographic Region - US, Europe, Asia-Pacific, and Rest of World
Markets Independently Analyzed by Annual Sales Figures in US$ Million for the
Years 2009 through 2015 (includes corresponding Graph/Chart)
III. COMPETITIVE LANDSCAPE
H1N1 Vaccines published by Global Industry Analysts, Inc. in April 1, 2010. This report consists of Pages: 221 and the price starts from US $ 3950.
